Home › Idiopathic Thrombocytopenic Purpura › New York › The Bronx
Idiopathic Thrombocytopenic Purpura clinical trials in The Bronx, NY
5 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around The Bronx (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
RecruitingPhase 2
- Montefiore Medical Center, The Bronx
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Montefiore Medical Center, The Bronx
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
RecruitingPhase 2
- Montefiore Medical Center, The Bronx
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Montefiore Medical Center, The Bronx
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
RecruitingPhase 3
- Montefiore Medical Center-Investigational Site Number: 8400012, The Bronx
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Washington, DC6 studies
- Greenville, NC6 studies
- Boston, MA6 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Houston, TX4 studies
- Portland, OR4 studies
- New Haven, CT3 studies
- Cedar Rapids, IA3 studies
- New Orleans, LA3 studies
Other studies in The Bronx
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer17 studies
- Acute Myeloid Leukemia15 studies
- Lung Cancer13 studies
- Cancer (all types)12 studies
- Cardiovascular Disease12 studies
- Heart Failure11 studies
- Prostate Cancer11 studies
- Metastatic Cancer9 studies
- Colorectal Cancer9 studies
- Head and Neck Squamous Cell Carcinoma9 studies
- Myelodysplastic Syndromes9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.